top of page
PHA Canada
More actions
Profile
Join date: Jun 6, 2024
Posts (50)
Mar 25, 2025 ∙ 1 min
Two tips for tax season
Tax season is upon us! The pulmonary hypertension community brought two tips to our attention. First, the usual disclaimer: we are not...
4
0
Mar 17, 2025 ∙ 1 min
Plain-language summary available for the TORREY seralutinib study
Seralutinib is a molecule that blocks inflammation, cell proliferation, and scarring responsible for pulmonary arterial hypertension. The...
0
0
Mar 13, 2025 ∙ 1 min
A Canadian Initiative: Exploring Adult PulmonaryHypertension
New Report Sheds Light on Pulmonary Hypertension in Canada Respiplus has just released a groundbreaking report, A Canadian Initiative:...
21
0
bottom of page